Gara Jalqabaatti › Infeekshinii Adenoviridae
Qorannoo klinikaalii Infeekshinii Adenoviridae Ameerikaa Keessatti hirmaatuu
Qorannoo 16 Infeekshinii Adenoviridae f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Columbus, OHQorannoo 5
- Cincinnati, OHQorannoo 4
- Washington, DCQorannoo 4
- Milwaukee, WIQorannoo 3
- New York City, NYQorannoo 3
Naannoon
- CaliforniaQorannoo 4
- MarylandQorannoo 4
- New YorkQorannoo 4
- OhioQorannoo 7
- TennesseeQorannoo 3
- WisconsinQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07544589The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01011712Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 85 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03665675Viral Infections in Healthy and Immunocompromised Hosts
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
6 Months – 120 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT01306084Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
Namoota walitti qabaa jiraSadarkaa 3
1 Day – 30 Years · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07225972Third Party Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 2
2 Days · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02532452Donor-Derived Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 1/2
4 Weeks · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02048332A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Namoota walitti qabaa jiraSadarkaa 3
2 Months · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07387367R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Namoota walitti qabaa jiraSadarkaa 1
3 Months – 26 Years · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT06926894TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin hundi · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT04013802R-MVST Cells for Treatment of Viral Infections
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05183490Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 21-Elb-2026 · NCT03878121Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 18 · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT05664126Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 65 Years · Saalaa hunda · Haaromfame 14-Hag-2025 · NCT06909110Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Namoota walitti qabaa jiraSadarkaa 2
1 Month – 79 Years · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT03266627Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 13-Cam-2025 · NCT04722029Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.